share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Director SANSONE GUY P

CVS Health | 4: Statement of changes in beneficial ownership of securities-Director SANSONE GUY P

西维斯健康 | 4:持股变动声明-董事 SANSONE GUY P
美股SEC公告 ·  11/25 18:12

Moomoo AI 已提取核心信息

On 11/21/2024, Guy P Sansone completed the acquisition of 2,200 shares of CVS Health common stock. The transaction was executed at a price of $57.1 per share, resulting in a total transaction value of approximately $125,620. This acquisition was categorized as a grant, award, or other acquisition, and the shares are held directly by Sansone.Following this transaction, Sansone's total beneficial ownership of CVS Health shares increased to approximately 8,360 shares. The transaction was completed as per the reported details, with no shares disposed of during this period. This acquisition reflects a strategic move by Sansone, potentially indicating confidence in the company's future performance.
On 11/21/2024, Guy P Sansone completed the acquisition of 2,200 shares of CVS Health common stock. The transaction was executed at a price of $57.1 per share, resulting in a total transaction value of approximately $125,620. This acquisition was categorized as a grant, award, or other acquisition, and the shares are held directly by Sansone.Following this transaction, Sansone's total beneficial ownership of CVS Health shares increased to approximately 8,360 shares. The transaction was completed as per the reported details, with no shares disposed of during this period. This acquisition reflects a strategic move by Sansone, potentially indicating confidence in the company's future performance.
2024年11月21日,Guy P Sansone完成了对2,200股CVS Health普通股的收购。该交易以每股57.1美元的价格执行,总交易价值约为125,620美元。此次收购被归类为赠款、奖励或其他收购,股份由Sansone直接持有。在这笔交易之后,三松对CVS Health股票的总实益所有权增加到约8,360股。根据报告的细节,该交易已完成,在此期间没有出售任何股份。此次收购反映了Sansone的战略举措,可能表明了对公司未来业绩的信心。
2024年11月21日,Guy P Sansone完成了对2,200股CVS Health普通股的收购。该交易以每股57.1美元的价格执行,总交易价值约为125,620美元。此次收购被归类为赠款、奖励或其他收购,股份由Sansone直接持有。在这笔交易之后,三松对CVS Health股票的总实益所有权增加到约8,360股。根据报告的细节,该交易已完成,在此期间没有出售任何股份。此次收购反映了Sansone的战略举措,可能表明了对公司未来业绩的信心。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息